Genflow reports sustained safety and efficacy three months after gene therapy dosing in dog trial

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the European biotechnology company focused on gene therapies for age-related diseases, has...